摘要
目的探讨湖北省某三甲医院执行国家带量采购政策后心血管系统药物使用情况的影响,为医保政策、药事管理和临床药学服务提供数据支持和参考。方法采用药物经济学方法对带量采购政策实施前后心血管系统药物的使用数量、销售金额、用药频度(defined daily dose system,DDDs)、日均费用(defined daily dose cost,DDC)进行回顾性分析。结果(1)该院执行的国家组织前三批带量采购14个品种DDC均大幅下降。调节血脂药和血管紧张素转换酶抑制剂的DDDs增幅分别达到44.18%、6.15%,钙通道阻滞剂、β-受体阻滞剂的DDDs降幅分别为-8.06%、-6.48%。(2)可替代品种DDDs均呈不同程度上升。除去培哚普利/吲达帕胺、氨氯地平/阿托伐他汀、阿利沙坦酯DDC下降,分别达到-62.34%、-16.07%、-13.76%,其它可替代品种DDC未见明显下降甚至略有提升。结论国家组织的前三批带量采购切实降低了部分患者的经济负担,医院心血管系统用药趋于更加科学合理,可替代药品需重点监控,建议纳入下一步带量采购范围。
Objective To explore the impact of the use of cardiovascular system drugs in class A tertiary hospital in Hubei province after the implementation of the national centralized drug procurement policy,provide data support and reference for the medical insurance policy,pharmaceutical affairs management and clinical pharmacy services.Methods The usage amount,sales amount,defined daily dose system(DDDs),defined daily dose cost(DDC)of cardiovascular system drugs before and after implementation of national centralized drug procurement policy were retrospectively analyzed by pharmacoeconomic method.Results(1)The DDC of 14 varieties purchased by the first three batches of national organizations implemented by the hospital significantly decreased.The DDDs of lipid-regulating drugs and angiotensin converting enzyme inhibitors increased by 44.18%and 6.15%respectively,while the DDDs of calcium channel blockers andβ-receptor blockers decreased by-8.06%and-6.48%respectively.(2)The DDDs of the succedaneums increased in different degrees.Except for the DDC of perdopril/indapamide,amlodipine/atorvastatin and alissartan decreased,reaching-62.34%,-16.07%and-13.76%respectively,the DDC of other succedaneums didn′t decrease significantly or even increased slightly.Conclusion The first three batches of national centralized drug procurement policy can effectively reduce the economic burden of some patients,and the hospital cardiovascular system medication tends to be scientific and reasonable,succedaneums need to be monitored and recommended to be included in the scope of next centralized drug procurement.
作者
徐子祺
尹大清
XU Ziqi;YIN Daqing(Department of Clinical Pharmacy,General Hospital of Central Theater Command,Wuhan Hubei 430070,China;不详)
出处
《联勤军事医学》
CAS
2023年第2期165-170,共6页
Military Medicine of Joint Logistics
关键词
带量采购药物
心血管系统药物
药事管理
合理用药
药物经济学
Centralized drug procurement
Cardiovascular system drugs
Pharmaceutical affairs management
Rational drug use
Pharmacoeconomics
